Pfizer

JULY 8, 2022

FDA Approval of their COVID-19 Vaccine COMIRNATY® For Adolescents 12 through 15 Years of Age. FDA Approval of their COVID-19 Vaccine COMIRNATY® For Adolescents 12 through 15 Years of Age. under emergency use authorization (EUA), and to date more than 9 million 12- to 15-year-old adolescents in the U.S.

FDA Approval 102

FDA Approval Vaccination Vaccine Clinical Trials 102

Pfizer

JULY 19, 2022

1 sub-lineage, for individuals 12 years of age and older. Food and Drug Administration (FDA) to support a potential variant-adapted vaccine and continue to submit additional data as advised by the agency. Pfizer-BioNTech COVID-19 Vaccine is FDA authorized to provide: Primary Series. Indication & Authorized Use.

Vaccination 100

Vaccination Vaccine Medicine Clinical Trials 100

Pfizer

JULY 8, 2022

Pfizer and BioNTech Submit a Variation to EMA for the Vaccination of Children 6 Months to less than 5 Years with COMIRNATY®. Pfizer and BioNTech Submit a Variation to EMA for the Vaccination of Children 6 Months to less than 5 Years with COMIRNATY®. Fri, 07/08/2022 - 09:45. Friday, July 08, 2022 - 11:00am.

Vaccination 81

Vaccination Vaccine Clinical Trials Clinical Trials 81